Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
The Nationwide Complete Most cancers Community (NCCN) has up to date its medical observe pointers to incorporate Trodelvy (sacituzumab govitecan-hziy) as a...
The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to zovegalisib together with Faslodex (fulvestrant) for some sufferers with...
